| Mini-invasive bypass at Gundersen Lutheran - Video Gundersen Lutheran Health System one of few heart centers in the nation performing minimally invasive multiple bypass surgery feedproxy.google.com |
Intellipharmaceutics CEO Molded by Biovail Bio Tuesday submits: Fifteen years ago, Dr. Isa Odidi performed magic as CSO of Biovail (NYSE:BVF), developing several blockbuster generics, including hard-to-manufacture copies of Bayer’s (BAYRY.PK) Adalat CC, Pfizer’s (PFE) Procardia XL and Novartis’ (NVS) Voltaren XR. “We have the same style here at Intellipharmaceutics (NASDAQ:IPCI) as we had at Biovail,” Dr. Odidi says in an exclusive interview with BioTuesday.ca. “It’s the library system approach. If you want a book at the library, you take it off the shelf. Likewise, we have a lot of compounds at various stages of development and as we file one, we bring another one forward.”Complete Story » seekingalpha.com |
How Life's Details Help Patients Researchers find having patients track "observations of daily living" can help in the treatment of those patients' health conditions. online.wsj.com |
Bristol Courts ZymoGenetics to Capitalize on Potential Hepatitis C Blockbuster The Burrill Report submits: By Michael FitzhughBristol-Myers Squibb (BMY) has lodged an offer to buy ZymoGenetics (ZGEN), its partner on a promising mid-stage hepatitis C drug, for $885 million in cash, bringing to a lucrative close the co-development and co-marketing partnership the companies struck in January 2009. Complete Story » seekingalpha.com |
Embracing Incentives for Efficient Health Care Hospitals and doctors are creating new entities that aim to provide more efficient health care, spurred by incentives in the federal health-overhaul law. online.wsj.com |